» Articles » PMID: 32015324

Clozapine-induced Transcriptional Changes in the Zebrafish Brain

Overview
Journal NPJ Schizophr
Date 2020 Feb 5
PMID 32015324
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Clozapine is an atypical antipsychotic medication that is used to treat schizophrenia patients who are resistant to other antipsychotic drugs. The molecular mechanisms mediating the effects of clozapine are not well understood and its use is often associated with severe side-effects. In this study, we exposed groups of wild-type zebrafish to two doses of clozapine ('low' (20 µg/L) and 'high' (70 µg/L)) over a 72-h period, observing dose-dependent effects on behaviour. Using RNA sequencing (RNA-seq) we identified multiple genes differentially expressed in the zebrafish brain following exposure to clozapine. Network analysis identified co-expression modules characterised by striking changes in module connectivity in response to clozapine, and these were enriched for regulatory pathways relevant to the etiology of schizophrenia. Our study highlights the utility of zebrafish as a model for assessing the molecular consequences of antipsychotic medications and identifies genomic networks potentially involved in schizophrenia.

Citing Articles

Identification of key long non-coding RNA-associated competing endogenous RNA axes in Brodmann Area 10 brain region of schizophrenia patients.

Sabaie H, Gholipour M, Asadi M, Abed S, Sharifi-Bonab M, Taheri M Front Psychiatry. 2022; 13:1010977.

PMID: 36405929 PMC: 9671706. DOI: 10.3389/fpsyt.2022.1010977.


Astrocyte Bioenergetics and Major Psychiatric Disorders.

Maly I, Morales M, Pletnikov M Adv Neurobiol. 2021; 26:173-227.

PMID: 34888836 DOI: 10.1007/978-3-030-77375-5_9.


The Role of Zebrafish and Laboratory Rodents in Schizophrenia Research.

Langova V, Vales K, Horka P, Horacek J Front Psychiatry. 2020; 11:703.

PMID: 33101067 PMC: 7500259. DOI: 10.3389/fpsyt.2020.00703.


Whole transcriptome in silico screening implicates cardiovascular and infectious disease in the mechanism of action underlying atypical antipsychotic side effects.

Malekizadeh Y, Williams G, Kelson M, Whitfield D, Mill J, Collier D Alzheimers Dement (N Y). 2020; 6(1):e12078.

PMID: 32864416 PMC: 7443741. DOI: 10.1002/trc2.12078.

References
1.
Burmeister M, McInnis M, Zollner S . Psychiatric genetics: progress amid controversy. Nat Rev Genet. 2008; 9(7):527-40. DOI: 10.1038/nrg2381. View

2.
Porcelli S, Balzarro B, Serretti A . Clozapine resistance: augmentation strategies. Eur Neuropsychopharmacol. 2011; 22(3):165-82. DOI: 10.1016/j.euroneuro.2011.08.005. View

3.
Siskind D, McCartney L, Goldschlager R, Kisely S . Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2016; 209(5):385-392. DOI: 10.1192/bjp.bp.115.177261. View

4.
Rajagopal S . Clozapine, agranulocytosis, and benign ethnic neutropenia. Postgrad Med J. 2005; 81(959):545-6. PMC: 1743348. DOI: 10.1136/pgmj.2004.031161. View

5.
Miyamoto S, Duncan G, Marx C, Lieberman J . Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry. 2004; 10(1):79-104. DOI: 10.1038/sj.mp.4001556. View